November 2 - 5, 2018
Sheraton New Orleans Hotel
New Orleans, Louisiana, USA
Abstract submission deadline: Wednesday, July 18
Advance registration deadline: Tuesday, September 18
Friday, Nov. 2
Saturday, Nov. 3
Sunday, Nov. 4
Monday, Nov. 5
Friday, Nov. 2
MICR Council Meet and Greet4-5 p.m.
Welcome and Opening Keynote Session5-6:45 p.m.
Keynote Lecture: How the National Cancer Institute is working to reduce cancer health disparitiesNorman E. Sharpless, National Cancer Institute, Bethesda, Maryland
Ninth Annual AACR Distinguished Lectureship on the Science of Cancer Health Disparities, funded by Susan G. Komen®: Towards understanding psychosocial and behavioral issues in cancer health disparitiesChanita Hughes-Halbert, Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina
Poster Session A / Opening Reception6:45-8:45 p.m.
Saturday, Nov. 3
Continental Breakfast with Professional Networking Roundtables8-9 a.m.
Plenary Session 1:
Ensuring Diversity in Precision Medicine Initiatives – Where Are We Now and What Are We Doing?
Session Chair: Elena Martinez, UCSD Moores Cancer Center, La Jolla, California9-10:30 a.m.
Ensuring diversity in precision medicine initiatives: Where are we now and what are we doing?Elena Martinez
The All of Us Research Program and precision engagement Dara Richardson-Heron, National Institutes of Health All of Us Initiative, Rockville, Maryland
What doctors, patients and the Latino community need to do to prepare for precision medicine?Gregory A. Talavera, San Diego State University, San Diego, California
Advocate perspective: Barriers to healthcare in minority communitiesCOL. (Ret.) James E. Williams, Jr., Pennsylvania Prostate Cancer Coalition and Intercultural Cancer Council, Camp Hill, Pennsylvania
Plenary Session 2:
Cancer Health Disparities in LouisianaSession Chair: Augusto C. Ochoa, Louisiana State University Health Sciences Center-Stanley S. Scott Cancer Center, New Orleans, Louisiana11 a.m.-12:30 p.m.
Understanding the molecular landscape of gastric premalignant stagesJovanny Zabaleta, Louisiana State University Health Sciences Center, New Orleans, Louisiana
Biobanking and genomic research: Understanding and acceptance of individuals underrepresented in clinical trialsTerry Davis, LSU Feist-Weiller Cancer Center, Shreveport, Louisiana
Exploring social determinants of cancer outcomes using multilevel spatial analysisRichard Scribner, Louisiana State University School of Medicine, New Orleans, Louisiana
MICR Professional Advancement Session / Lunch on Own (for those not attending PAS)12:30-2 p.m.Top of page
Educational Sessions 1 & 22-3 p.m.
Educational Session 1: Progress in Colorectal Cancer – From Screening to SurvivorshipSession Chair: Samir Gupta, University of California, San Diego, La Jolla, California
Progress in colorectal cancer screening: Past, present, and future
Darrell M. Gray,II, The Ohio State University, Columbus, Ohio
Advocate perspective: The road traveled – Challenges, changes, and survivorshipCandace Henley, The Blue Hat Foundation, Chicago, Illinois
Follow-up of abnormal colorectal cancer screening: Challenges and solutions
Folasade P. May, UCLA David Geffen School of Medicine, Los Angeles, California
Improving outcomes for all colorectal cancer survivorsJudith Lee Smith, Centers for Disease Control and Prevention, Atlanta, Georgia
Educational Session 2: Training the Next Generation of Cancer Health Disparities ResearchersSession Chair: Sanya A. Springfield, National Cancer Institute-Center to Reduce Cancer Health Disparities, Bethesda, Maryland
Emerging priorities for the Center to Reduce Cancer Health Disparities in diversity workforce training and cancer health disparities research Sanya A. Springfield
The bridge less traveled: Diversifying the doctoral pipeline in public health and social/behavioral research Rena J. Pasick, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
Lessons learned from seventeen years of cancer research experiences program for underrepresented high school and college students Karen Burns White, Dana-Farber Cancer Institute, Boston, Massachusetts
Innovations in cancer disparities training: What is role of the community?Lorna H. McNeill, The University of Texas MD Anderson Cancer Center, Houston, Texas
North Carolina Central University and Duke Cancer Institute’s collaborative cancer research and education program: Connecting cancer disparities translational research, clinical trials operations, and community engagementNadine J. Barrett, Duke Cancer Institute, Durham, North Carolina
Concurrent Sessions 1 & 23-4 p.m.
Concurrent Session 1: Using Emerging Approaches and Technologies to Increase Participation of Minorities, Rural Populations, and Small Oncology Centers
Session Chair: Brian M. Rivers, Morehouse School of Medicine, Atlanta, Georgia
Using electronic health records for participant recruitment: Policies and outcomesChanita Hughes-Halbert, Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina
Assembling study cohorts for molecular characterization from medically underserved populations: A view from the trenches
Kevin L. Gardner, Columbia University, New York, New York
Concurrent Session 2: Immigration and Refugee Populations and Cancer Health DisparitiesSession Chair: Deborah O. Erwin, Roswell Park Cancer Institute, Buffalo, New York
Engaging refugees and immigrants in breast health educationMay Shogan, International Institute of Buffalo, Buffalo, New York
Effect of migration to the US on health characteristics of the African diaspora Camille C. R. Ragin, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Recent Discoveries and Hot Topics in Cancer Health Disparities 1Session Chair: Adam B. Murphy, Northwestern University, Chicago, Illinois4:30-6 p.m.
Factors associated with dual use of electronic cigarettes among adult American Indians who smoke: A Cherokee Nation cohort studyDorothy Rhoades, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Contextualizing the association between social isolation and smoking among socioeconomically disadvantaged adults: Psychosocial, life-contextual, and healthcare factorsKassandra Alcaraz, American Cancer Society, Atlanta, Georgia
Disparities in work status after treatment for breast cancer: A controlled, longitudinal studyVictoria Blinder, Memorial Sloan Kettering Cancer Center, New York, New York
Engaging in physical activity after a cancer diagnosis: A Detroit ROCS StudyJennifer Beebe-Dimmer, Wayne University Karmanos Cancer Institute, Detroit, Michigan
A genetic variant at 6q25 associated with estrogen receptor negative breast cancer subtypes in Peruvian breast cancer patientsKatie Marker, University of California, Berkeley, California
Research on prostate cancer in men of African ancestry: Defining the roles of genetics, tumor markers and social stressAnn Hamilton, University of Southern California Keck School of Medicine, Los Angeles, California
Poster Session B / Reception
Evening Off / Dinner on Own8 p.m.Top of page
Sunday, Nov. 4
Plenary Session 3:
‘Omics Studies in Cancer DisparitiesSession Chair: John D. Carpten, USC Keck School of Medicine, Los Angeles, California9-10:30 a.m.
The role of genomic and microbiomics in colorectal cancer among African American patients
Hassan Ashktorab, Howard University, Washington, D.C.
Mechanistic differences in early-onset colorectal cancerNathan A. Ellis, University of Arizona Cancer Center, Tucson, Arizona
Exploring the impact of African Ancestry in tumor immune response, a possible role in disparate clinical outcomesMelissa B. Davis, Henry Ford Health Systems, Detroit, Michigan
Recent Discoveries and Hot Topics in Cancer Health Disparities 2Session Chair: Matthew P. Banegas, Kaiser Permanente, Portland, Oregon11 a.m.-12:30 p.m.
Racial differences in financial toxicity among metastatic breast cancer patientsCleo Samuel, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina
Higher expression of SATB2 gene in hepatocellular carcinoma of African American patients determines aggressiveness phenotypes than those in Caucasian AmericansRakesh Srivastava, LSUHSC-NO, New Orleans, Louisiana
MicroRNA-1205 regulation of FRYL and aggressive prostate cancer in men of African ancestryMichelle Naidoo, Hunter College of the City University of New York, New York, New York
Fewer rural cancer patients treated with antineoplastic agentsCathy Bradley, University of Colorado, Aurora, Colorado
Racial differences in characteristics of early- vs late-onset colorectal cancer among VeteransMonalesia Chapman, University of North Carolina-Greensboro, Durham VA Healthcare System, HIllsborough, North Carolina
CRC screening in rural community clinics using the Fecal Immunochemical Test (FIT): Issues with repeat screeningConnie Arnold, Feist-Weiller Cancer Center and LSU Health Sciences Center, Shreveport, Louisiana
Educational Sessions 3 & 42:30-3:30 p.m.
Educational Session 3: Cancer Health Disparities – Emerging System-Level Discoveries of the Molecular DriversSession Chair: Isidore Rigoutsos, Thomas Jefferson University, Philadelphia, Pennsylvania
Advocate perspective:Diversity in research – A missing link to eliminate health disparitiesBarbara Segarra-Vazquez, University of Puerto Rico and Susan G. Komen, San Juan, Puerto Rico
Racial differences in the lung cancer transcriptome: Insights from coding, non-coding and alternative polyadenylated genesBrid Ryan, National Institutes of Health, Bethesda, Maryland
Intrinsic and extrinsic contributions of mitochondrial DNA to metastatic efficiency: A genetic explanation for disparities in metastasis efficiency?Danny R. Welch, University of Kansas Cancer Center, Kansas City, Kansas
Novel nuclear and mitochondrial RNAs that are linked to key pathways and depend on sex, population origin, race, tissue and diseaseIsidore Rigoutsos
Educational Session 4: Progress in Liver Cancer – From Screening to SurvivorshipSession Chair: Lewis R. Roberts, Mayo Clinic College of Medicine, Rochester, Minnesota
Liver cancer screening: How much progress have we really made?Amit Singal, UT Southwestern, Dallas, Texas
Surgical resection in liver and biliary cancersChee-Chee H. Stucky, Mayo Clinic Arizona, Phoenix, Arizona
Systemic therapy in HCC: Making progress against a major cancer problemRichard S. Finn, University of California, Los Angeles, Santa Monica, California
Advocate perspective: The effect of compounding disparities in driving liver cancer incidence and mortality ratesDonna R. Cryer, Global Liver Institute, Washington, D.C.
Concurrent Sessions 3 & 4
Concurrent Session 3: Asian American / Native Hawaiian / Pacific Islander Cancer Health DisparitiesSession Chair: Scarlett Lin Gomez, University of California, San Francisco, San Francisco, California
Advocate perspective: Speaking truth to power – From cancer patient to survivor to community health activistSusan Matsuko Shinagawa, San Diego Community Health Equity Partners, Spring Valley, California
Lung cancer incidence and risk factors in never-smoking Asian American, Native Hawaiian, and Pacific Islander women: The development of a multilevel integrated dataset of EHR health record, cancer registry, and environmental dataMindy C. DeRouen, University of California, San Francisco, San Francisco, California
Racial/ethnic differences in obesity-associated risk factors of liver cancerUnhee Lim, University of Hawaii Cancer Center, Honolulu, Hawaii
A family-focused lay health worker approach to promote smoking cessation, healthy eating, and physical activity among Asian Americans Janice Y. Tsoh, University of California, San Francisco, San Francisco, California
Top of page
Concurrent Session 4: Global Cancer Health DisparitiesSession Chair: Laura Fejerman, University of California, San Francisco School of Medicine, San Francisco, California
Precision medicine in cancer: Opportunities and challenges in Latin AmericaAndrea S. Llera, Fundacion Instituto Leloir, Buenos Aires, Argentina
Addressing prostate cancer disparities through precision public health: The CaPTC experienceFolakemi T. Odedina, University of Florida, Gainesville, Florida
Breast cancer and African ancestryLisa A. Newman, Weill Cornell Medicine, New York, New York
Plenary Session 4:
Quality of Cancer Care, Health Care Costs, and DeliverySession Chair: Michael T. Halpern, Temple University College of Public Health, Philadelphia, Pennsylvania5-6:30 p.m.
Advocate perspective: Disparities in access to and quality of cancer careShelley Fuld Nasso, National Coalition for Cancer Survivorship, Silver Spring, Maryland
Coverage and access: State Medicaid policies and disparities in receiving high-quality cancer careMichael T. Halpern
Disparities in access and outcomes: Actions and consequencesSandra L. Wong, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
Evening Off / Dinner on Own6:30 p.m.
Monday, Nov. 5
Continental Breakfast with Professional Networking Roundtables8-9 a.m.
Discoveries and Hot Topics in Cancer Health Disparities 3Session Chair: Mariana C. Stern, USC Norris Comprehensive Cancer Center, Los Angeles, California9-10:30 a.m.
Geospatial analytics and sensitivity/specificity assessments to inform liver cancer preventionShannon Lynch, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Do Latinas with breast cancer who live in ethnic enclaves have better or worse survival? Analysis of cancer registry data from California and TexasSalma Shariff-Marco, University of California San Francisco, San Francisco, CaliforniaSandi L. Pruitt, UT Southwestern Medical Center, Dallas, Texas
Do segregated neighborhoods buffer the stressful effects of low coping among Black breast cancer survivors?Jesse Plascak, Rutgers, The State University of New Jersey, Piscataway, New Jersey
Investigating the determinants of racial disparities in ovarian cancer incidence: The OCWAA consortiumVeronica Setiawan, University of Southern California, Los Angeles, California
The mediating role of unmet social support needs on the racial/ethnic disparity in psychosocial stress among breast cancer patientsCarola Sánchez Díaz, University of Illinois at Chicago, Chicago, Illinois
Prognostic role of androgen receptor in triple negative breast cancer: A global multi-institutional experienceShristi Bhattarai, Georgia State University, Atlanta, Georgia
Plenary Session 5:
Leveraging Big Data and Integrative Data Analysis to Address Cancer Health in Disparities in Small PopulationsSession Chair: Lynne Penberthy, National Institutes of Health, Rockville, Maryland10:45 a.m.-12:15 p.m.
New opportunities using real-world data from SEER to support health disparities researchLynne Penberthy
Advancing cancer disparities research through data integration: The multiethnic cohort study Iona Cheng, University of California, San Francisco, San Francisco, California
Genetic testing, treatment and mortality after diagnosis of breast cancer or ovarian cancer: The SEER-GeneLINK Initiative Allison W. Kurian, Stanford University, Stanford, California
Plenary Session 6: Standardization of Tools and Measures for the Next Generation of Cancer Health Disparities ResearchSession Chair: Richard P. Moser, National Cancer Institute - Division of Cancer Control and Population Sciences, Bethesda, Maryland 12:15-1:45 p.m.
Tools for assessing social determinants of healthScarlett Lin Gomez, University of California, San Francisco, California
Closing Remarks1:45 p.m.
Ivis Febus-Sampayo, SHARE Cancer Support, New York, New York
Laura Fejerman, University of California, San Francisco School of Medicine, San Francisco, California
Scarlett Lin Gomez, University of California, San Francisco,
San Francisco, California
Augusto C. Ochoa, Louisiana State University Health Sciences Center-Stanley S. Scott Cancer Center
Brian M. Rivers, Morehouse School of Medicine, Atlanta, Georgia
Top of page